AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Hertraz 150mg Injection

Prescription Icon
Prescription Required

Marketer

Mylan Pharmaceuticals Pvt Ltd - A Viatris Company

Salt Composition

Trastuzumab (150mg)

Overview Hertraz 150mg Injection

Trastuzumab 150mg injection treats breast and gastric cancers by targeting and destroying HER2-positive cancer cells. Administered intravenously by a healthcare professional, the dosage and frequency are determined individually by your physician based on your specific condition and may vary. Adhere strictly to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may not be immediately apparent, requiring weeks or months; discontinue only under medical guidance. Common side effects encompass nausea, headache, skin rash, sleep disturbances, and infections. This medication can lower blood cell counts, increasing infection risk, necessitating regular blood tests monitoring blood cell levels, cardiac function, liver health, and uric acid. Report shortness of breath, cough, chills, or limb swelling to your doctor immediately. Inform your healthcare provider of all other medications you're taking, as interactions are possible. Avoid conception during treatment; effective contraception is crucial for both partners.

Primary Ingredients of Hertraz 150mg Injection

No text provided. Please provide the text you wish to be rewritten.

Uses of Hertraz 150mg Injection

Malignancies of the breast and stomach.

Major Benefits of Hertraz 150mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Hertraz 150mg Injection:

  • Anemia (low number of red blood cells)
  • Chills
  • Common cold
  • Cough
  • Decreased blood cells (red cells, white cells, and platelets)
  • Diarrhea
  • Fatigue
  • Fever
  • Headache
  • Heart failure
  • Infection
  • Insomnia (difficulty in sleeping)
  • Mucosal inflammation
  • Nausea
  • Rash
  • Stomatitis (Inflammation of the mouth)
  • Taste change
  • Upper respiratory tract infection
  • Weight loss

How to use Hertraz 150mg Injection:

This medication will be administered by your physician or their registered nurse; please do not attempt self-medication.

How Hertraz 150mg Injection works:

Trastuzumab 150mg injection, a genetically engineered IgG1 monoclonal antibody, targets HER2 receptors—proteins fueling excessive breast and gastric cancer cell growth. By binding to HER2, it neutralizes these receptors, thereby halting cancer cell proliferation and disrupting multiple downstream signaling cascades crucial for tumor development.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concomitant use of Hertraz 150mg Injection and alcohol may lead to increased sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Hertraz 150mg Injection during pregnancy poses a confirmed risk to the fetus. Nevertheless, in exceptional, life-threatening circumstances, a physician might exceptionally prescribe it when the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The administration of Hertraz 150mg Injection while breastfeeding is likely inadvisable. Preliminary human studies indicate a potential for the medication to transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

Hertraz 150mg Injection's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

The use of Hertraz 150mg Injection in individuals with kidney impairment is likely safe. Preliminary evidence indicates dose modification may be unnecessary. Physician consultation is recommended.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Hertraz 150mg Injection to individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Hertraz 150mg Injection :

Should you forget a Hertraz 150mg Injection dose, seek your physician's advice.

Facts to Know About Hertraz 150mg Injection

LabelValue
Chemical Category Monoclonal antibody
Developing Habits No.
Treatment Category Cancer Medications
Action Category Monoclonal Antibody HER2/neu (ErbB2) Inhibitor

FAQs on Hertraz 150mg Injection

Hertraz 150mg Injection may cause side effects including sore throat, fever, chills, fatigue, pale skin, nosebleeds, and unusual bleeding or bruising. Other possible side effects are stomach pain, seizures, hallucinations, muscle cramps and spasms, nausea, vomiting, loss of appetite, rapid heartbeat, urine discoloration, decreased or painful urination, difficulty urinating, and signs of infection. Seek immediate medical attention if any of these occur.
Effective contraception is recommended for women of childbearing age throughout Hertraz 150mg Injection therapy and for seven months afterward. Pregnancy planning may resume seven months post-treatment.
Herceptin 150mg injections should be administered to early-stage breast cancer patients for one year, or until disease recurrence, whichever comes first. Treatment should not exceed one year.
Herceptin 150mg Injection does not require fasting beforehand. Administration must be supervised by an oncologist and performed only by a qualified healthcare professional.
Hertraz 150mg Injection comes in two formulations: intravenous (IV) infusion and subcutaneous (under-the-skin) injection. Always verify the product label to ensure correct administration. The IV formulation is exclusively for intravenous use; it must not be given subcutaneously. Your doctor may change your treatment between IV and subcutaneous Hertraz 150mg Injection if clinically indicated.
Hertraz 150mg Injection, a monoclonal antibody, targets the HER2 protein found on some cancer cells. Its effectiveness relies on binding to HER2 to inhibit cancer growth. Consequently, it's only indicated for patients with HER2-positive cancer; it's ineffective and inappropriate for those with HER2-negative cancer.
Using Hertraz 150mg Injection with anthracyclines (like doxorubicin) can harm your heart. Therefore, your doctor must assess your heart health before and during treatment.
Cardiac evaluations are necessary at treatment initiation, every three months during treatment, and every six months post-treatment for 24 months following the last Hertraz 150mg Injection. Patients with pre-existing cardiac conditions require evaluations every 12 weeks.
Hertraz 150mg Injection
16,005
MRP 19,500
17% off